NCT04379024View on ClinicalTrials.gov

Pilot Study of Effects of Duavee® on Imaging and Blood Biomarkers In Women With Menopausal Symptoms

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

July 31, 2021

Conditions
Focus of Study is Healthy Women at Risk for Breast Cancer
Interventions
DRUG

DUAVEE 0.45Mg-20Mg Tablet

One capsule daily for 6 months (+/- 1 month)

Trial Locations (1)

66160-7820

University of Kansas Medical Center, Kansas City

Sponsors
All Listed Sponsors
collaborator

Breast Cancer Research Foundation

OTHER

lead

Carol Fabian, MD

OTHER